Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

Antibiotics are overused by some and out of reach for others - fuelling resistance and leaving deadly gaps in care.

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Gut bacteria produce metabolites that influence drug metabolism and affect immune cell function, potentially enhancing or ...

Treating urine infections is becoming increasingly challenging due to rising antibiotic resistance. Here's what's driving ...

The following is a summary of “Educational interventions and contextual factors for optimising antibiotic prescription in ...

If the body is serious about achieving its goal of making America healthier, it might consider talking to a farmer first.

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

This is the first real-world evidence that expanded prophylactic antibiotic use can reduce community transmission of iGAS.

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

A new antibiotic that has the potential to save millions of lives has entered its last phase of human testing. Swiss ...

Swiss drugmaker Roche is advancing a new antibiotic into its final human testing phase, potentially saving millions from ...